Mauro David J 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jun 7, 2023
Insider Transaction Report
Form 4
Mauro David J
Chief Medical Officer
Transactions
- Award
Class A Common Stock
2023-06-01+190,713→ 190,713 total - Award
Stock Option (Right to Buy)
2023-06-01+381,426→ 381,426 totalExercise: $8.77Exp: 2033-06-01→ Class A Common Stock (381,426 underlying)
Footnotes (2)
- [F1]This RSU vests as to one fourth (1/4th) of the units subject to the RSU on August 15, 2024 and one sixteenth (1/16th) every three months thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
- [F2]This option vests as to one fourth (1/4th) of the shares subject to the option on June 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.